Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
J Sep Sci ; 41(5): 1025-1038, 2018 Mar.
Article de Anglais | MEDLINE | ID: mdl-29227021

RÉSUMÉ

Tangzhiqing formula, a Chinese herbal formula, is used for the treatment of type II diabetes and prediabetes. Although its effectiveness has been certified by clinical use, its absorbed chemical constituents are not comprehensively represented. Thence, in order to reveal potential bioactive components and metabolism of Tangzhiqing formula, an ultra-high performance liquid chromatography with quadrupole time-of-flight mass spectrometry method was developed. A total of 86 absorbed components, including 38 prototype compounds and 48 metabolites, were identified in rat plasma, urine, and feces after oral administration of Tangzhiqing formula. This was the first systematic study on the chemical constituents and metabolic profiling of Tangzhiqing formula. The results indicated that alkaloids and flavonoids were main absorbed components, and glucuronidation and sulfation were the major metabolites. Moreover we concluded that alkaloids and flavonoids first underwent demethylation and hydrolysis reactions before biotransformed to phase II metabolites. This study provided valuable data for safety estimation of Tangzhiqing formula, which will be advantageous for clinical application.


Sujet(s)
Médicaments issus de plantes chinoises/analyse , Administration par voie orale , Chromatographie en phase liquide à haute performance , Médicaments issus de plantes chinoises/administration et posologie , Médicaments issus de plantes chinoises/métabolisme , Spectrométrie de masse , Structure moléculaire , Facteurs temps
2.
Biomed Chromatogr ; 31(12)2017 Dec.
Article de Anglais | MEDLINE | ID: mdl-28556969

RÉSUMÉ

Quercetin, a kind of major flavonoid found in many traditional chinese medicines, is an effective substance for treatments such as lowering blood lipids. However, the studies on quercetin have been mainly focused on its pharmacological effect; the treatment of diseases on a material basis, particularly the metabolites derived from quercetin in vivo, has not been evaluated. In this study, we determined the levels, distributions and types of quercetin's metabolites in plasma, urine, feces and bile of rats after a single oral administration of quercetin at a dose of 80 mg/kg, using ultra-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry (UPLC-Q-TOF/MS). A total of 36 metabolites of quercetin were identified, including 11 metabolites in plasma, 34 metabolites in urine, 12 metabolites in feces and 21 metabolites in bile. The results showed that phase I metabolites were reduction metabolites and phase II metabolites mainly included glucuronidation, sulfation and methylation metabolites. These results provide important information on the metabolism of quercetin, which will be helpful for its further development and utilization.


Sujet(s)
Chromatographie en phase liquide à haute performance/méthodes , Spectrométrie de masse/méthodes , Métabolomique/méthodes , Quercétine/analyse , Quercétine/métabolisme , Administration par voie orale , Animaux , Mâle , Quercétine/administration et posologie , Quercétine/composition chimique , Rats , Rat Wistar
3.
J Pharm Biomed Anal ; 140: 71-80, 2017 Jun 05.
Article de Anglais | MEDLINE | ID: mdl-28342305

RÉSUMÉ

Nuciferine, a major alkaloid found in Nelumbinis Folium, exhibits a broad spectrum of bioactivities, such as antiobesity, anti-diabetes and anti-inflammatory. However, many research regarding nuciferine focused on the extraction, isolation and biological activity, the metabolism is not comprehensively explained in vivo. Thence, the present of this paper is to establish a simple method for speculating metabolites of nuciferine. A total of 15 metabolites were detected and tentatively identified through ultra high performance liquid chromatography-diode array detection-quadrupole time-of-flight mass spectrometry (UHPLC-DAD-QTOF-MS), including 7 new metabolites. Among them, we also discovered a previously unmentioned metabolically active site at the C1-OCH3 position. These metabolites suggested that demethylation, oxidation, glucuronidation and sulfation were major metabolic pathways. This study provided significant experiment basis for its safety estimate and valuable information about the metabolism of nuciferine, which will be advantageous for new drug development.


Sujet(s)
Spectrométrie de masse , Administration par voie orale , Animaux , Aporphines , Bile , Chromatographie en phase liquide à haute performance , Fèces , Rats
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE